| Name | CRTh2 antagonist 3 |
|---|---|
| Synonyms |
2-[2-[[2-(2,6-Dimethylphenoxy)ethyl]thio]-1-benzimidazolyl]acetic Acid
1H-Benzimidazole-1-acetic acid, 2-[[2-(2,6-dimethylphenoxy)ethyl]thio] 2-(2-((2-(2,6-Dimethylphenoxy)ethyl)thio)-1H-benzo[d]imidazol-1-yl)acetic acid |
| Description | CRTh2 antagonist 3 is a potent chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTh2) antagonist[1]. CRTh2 antagonist 3 (compound 4) also enhances the activity of PDK1 toward a short peptide substrate, with an EC50 of 2 μM and a Kd of 8.4 μM. CRTh2 antagonist 3 has the potential for cardiovascular inflammation[2]. |
|---|---|
| Related Catalog | |
| Target |
CRTh2[1] EC50: 2 μM (PDK1)[2] Ki: 8.4 μM (PDK1)[2] |
| References |
| Molecular Formula | C19H20N2O3S |
|---|---|
| Molecular Weight | 356.44 |